SCHEMBL12817667

SCHEMBL12817667

Cc1nc2cc(S(=O)(=O)N3CCOc4ccc(-c5ccc(C#N)s5)cc43)ccc2o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.39
▸ CYP2C9 P11712 2/20 0.38
▸ GCK P35557 1/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ MAPT P10636 3/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PDE3B Q13370 4/20 0.35
▸ PDE3A Q14432 4/20 0.35
▸ CPT1A P50416 3/20 0.34
▸ CPT1B Q92523 3/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818990 0.93 CYP2C9 (0.38) PGRCYP2C9GCKMEN1KMT2A
SCHEMBL12818698 0.87 CYP2C9 (0.37) CYP2C9GCKMEN1KMT2AMAPT
SCHEMBL12817769 0.87 CYP2C9 (0.38) CYP2C9GCKMEN1KMT2AMAPT
SCHEMBL12819156 0.85 PGR (0.39) PGRGCKMEN1KMT2AMAPT
SCHEMBL12818451 0.84 GCK (0.39) PGRGCKMEN1KMT2AMAPT
SCHEMBL12817802 0.84 LMNA (0.42) CYP2C9MEN1KMT2AMAPTTP53
SCHEMBL12818652 0.84 MEN1 (0.40) CYP2C9GCKMEN1KMT2AMAPT
SCHEMBL12818531 0.84 PKM (0.45) PGRCYP2C9MEN1KMT2APDE3B
SCHEMBL1818674 0.84 CYP2C9 (0.53) PGRCYP2C9MEN1KMT2AMAPT
SCHEMBL12817925 0.84 PGR (0.40) PGRGCKMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback